Search For A Disorder
Cone-rod dystrophies (CRD) are a group of pigmentary retinopathies that have early and important changes in the macula. Cone dysfunction occurs first and is often followed by rod photoreceptor degeneration.
Common initial symptoms are decreased visual acuity, dyschromatopsia, and photophobia which are often noted in the first decade of life. Night blindness occurs later as the disease progresses. A fine nystagmus is also common. Visual field defects include an initial central scotoma with patchy peripheral defects followed by larger defects in later stages. The fundus exam can be normal initially, but is followed by pigmentary bone spicule changes, attenuation of retinal vessels, waxy pallor of the optic disc and retinal atrophy. A ring maculopathy surrounding the fovea is usually evident. The ERG first reveals photopic defects and later scotopic changes. Fluorescein angiography and fundus autofluorescence generally reveal atrophic retinopathy. Many patients eventually become legally blind as the disease progresses and some end up with no light perception.
Cone-rod dystrophies are a group of disorders separate from rod-cone dystrophies where the primary defect is in the rod photoreceptors with typical pigmentary changes in the peripheral retina. The progression of vision loss is generally slower in rod-cone dystrophies. Cone dystrophies comprise another group of disorders with exclusive cone involvement in which the macula often has a normal appearance in association with loss of central acuity.
No systemic disease is associated with simple cone-rod dystrophies. See below for syndromal disorders with cone-rod dystrophy.
Non-syndromic cone-rod dystrophies can be either autosomal dominant, autosomal recessive or X-linked and are caused by defects in at least 17 different genes. This database entry discusses only the autosomal disorders. See X-linked cone-rod dystrophies in a separate entry.
Cone-rod dystrophies inherited in an autosomal dominant pattern include:
CORD2 (120970) is caused by mutations in CRX at 19q13.3, a homeobox gene responsible for the development of photoreceptor cells. These are responsible for 5-10% of autosomal dominant cone-rod dystrophy cases (602225) and can also cause one type (LCA7) of Leber congenital amaurosis (602225) and a late-onset retinitis pigmentosa phenotype.
CORD5 (600977) is caused by mutations in the PITPNM3 gene at 17p13.1.
CORD6 (601777) is caused by a mutation in GUCY2D in a similar location on chromosome 17.
CORD7 (603649) is caused by mutations in RIMS1 at 6q12-q13.
Mutations in AIPL1 (604392), located in the same region, usually causes a form of Leber congenital amaurosis (LCA4) as well as retinitis pigmentosa (604393) but has also been reported in a cone-rod pigmentary retinopathy.
CORD11 (610381) is caused by mutations in RAXL1 (19p13.3).
CORD12 (612657) results from mutations in the PROM1 gene (4p15.3).
Mutations in the gene GUCA1A on chromosome 6p21.1 causes CORD14 (602093).
An as yet unclassified autosomal dominant type of cone-rod dystrophy has recently been localized to 10q26.
Cone-rod dystrophies inherited in an autosomal recessive pattern include:
CORD8 (605549) has been found in a single consanguineous family and the mutation localized to 1q12-q24.
ADAM9 (602713) at 8p11 and 8p11.23 contains mutations that have been shown to cause autosomal recessive CORD9 in several consanguineous families.
Mutations in RPGRIP1 (14q11) are responsible for CORD13 (608194).
The CDHR1 gene (10q23.1) contains mutations that cause CORD15 (613660).
Syndromal cone-rod dystrophies:
Cone-rod dystrophy may also be associated with other syndromes, such as Bardet-Biedl syndrome (209900), or spinocerebellar ataxia Type 7 (164500), autosomal recessive amelogenesis imperfecta with cone-rod dystrophy or Jalili syndrome (217080), neurofibromatosis type I (162200), and hypotrichosis with juvenile macular dystrophy and alopecia (601553). Metabolic disorders associated with cone-rod dystrophy include Refsum disease with phytanic acid abnormality (266500) and Alport syndrome (301050).
There is no treatment for these dystrophies but red-tinted lenses provide comfort and may sometimes improve acuity to some extent. Low vision aids can be helpful.